Pfizer successfully completes the acquisition of Therachon
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
List view / Grid view
News
Jet-lag medication approved by MHRA
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
ABPI finds £377 million spent on UK R&D
The ABPI has reported findings from its transparency initiative, Disclosure UK, stating that R&D investment grew significantly from 2017 to 2018.
Former FDA Commissioner joins Pfizer’s board of directors
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
Artificial DNA can control release of active ingredients from drugs
A team at the Technical University of Munich have made it possible for nano particles to be released in sequence with the use of artificial DNA.
EMA releases medicinal approval recommendations
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.
Cryo-electron microscope market predicted to rise 8.97 percent
A report has projected that by 2025, the global cryo-electron microscope market will be worth US$632.3 million.
Pharmaceutical company combats counterfeit Viagra
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong through serialisation technology.
New drug delivery implant could treat patients remotely
Researchers have developed a new drug delivery system that can be remotely controlled to administer patients with medication.
Medical journals found to restrict access to pharma industry research
A new report has stated that the majority of medical journals restrict their content for pharmaceutical industry professionals.
Revealed structure of glucagon fibrils could improve drug formulation
Researchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.
AbbVie is to acquire Allergan in a ‘transformative transaction’
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
Government letter advises pharma industry for no-deal Brexit
The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
New stable nanoemulsions could change drug delivery
Researchers have developed a method of creating stable nanoemulsions which could be used in new drug delivery processes.
Registration is open for the UK’s only lab-dedicated exhibition
Keynote speakers announced for Lab Innovations 2019.
